Sepsis & infection

Early Empiric Antibiotic Use in Patients Hospitalized With COVID-19: A Retrospective Cohort Study*

Crit Care MedPublished Retrospective cohort study

Authors' conclusion

Although treatment of COVID-19 patients with empiric antibiotics has declined during the pandemic, the frequency of use remains high. There is significant inter-center variation in antibiotic prescribing practices and evidence of potential harm.

Study context

Population
Patients hospitalized with COVID-19, 66 US health systems in the N3C database
Participants
322,867 first hospitalizations
Exposure
Early empiric antibiotic use vs no early antibiotic use
  • Early empiric antibiotic use (EEAU)n = 43,089
Outcome
Early empiric antibiotic use over time
Methodological detailspropensity-matched, multicentre (66 health systems)
  • Propensity-matched
  • Multicentre (66 health systems)

Main finding

As reported in the abstract

Antibiotic use in March 2020
23%
Antibiotic use in June 2022
9.6%
Significant inter-center variation in EEAU (deviance explained 7.33% vs 20.0%)
p < 0.001

Observational data: associations, not effects.

Further findings

Factors associated with EEAU

OR (95% CI)
Mechanical ventilation before day 23.57 (3.42–3.72)
ECMO before day 22.14 (1.75–2.61)
Early vasopressor use1.85 (1.78–1.93)
OutcomeOR (95% CI)
In-hospital mortalityAfter propensity matching1.27 (1.23–1.33)
Prolonged mechanical ventilationAfter propensity matching1.65 (1.50–1.82)

Factors associated with EEAU

Region of residence not associated with EEAU

Safety

OutcomeOR (95% CI)
Late broad-spectrum antibiotic exposureAfter propensity matching3.24 (2.99–3.52)
Late Clostridium difficile infectionAfter propensity matching1.60 (1.37–1.87)

Original publication

Early Empiric Antibiotic Use in Patients Hospitalized With COVID-19: A Retrospective Cohort Study*. Crit Care Med. Published 1 May 2023. doi:10.1097/ccm.0000000000005901

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.